MRC

Mercator MedicalWSE:MRC Stock Report

Market Cap

zł1.8b

7D

-2.1%

1Y

-57.2%

Updated

17 Sep, 2021

Data

Company Financials +
MRC fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

MRC Overview

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables in Europe, Russia, and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Mercator Medical
Historical stock prices
Current Share Pricezł166.10
52 Week Highzł145.20
52 Week Lowzł770.00
Beta3.48
1 Month Change-8.84%
3 Month Change-26.99%
1 Year Change-57.19%
3 Year Change985.62%
5 Year Change849.69%
Change since IPO1,033.79%

Recent News & Updates

Jul 13
Is Now The Time To Put Mercator Medical (WSE:MRC) On Your Watchlist?

Is Now The Time To Put Mercator Medical (WSE:MRC) On Your Watchlist?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...

May 19
Mercator Medical's (WSE:MRC) Promising Earnings May Rest On Soft Foundations

Mercator Medical's (WSE:MRC) Promising Earnings May Rest On Soft Foundations

Mercator Medical S.A.'s ( WSE:MRC ) robust earnings report didn't manage to move the market for its stock. We did some...

Shareholder Returns

MRCPL Medical EquipmentPL Market
7D-2.1%-1.9%-0.5%
1Y-57.2%-45.9%41.2%

Return vs Industry: MRC underperformed the Polish Medical Equipment industry which returned -40.6% over the past year.

Return vs Market: MRC underperformed the Polish Market which returned 41.9% over the past year.

Price Volatility

Is MRC's price volatile compared to industry and market?
MRC volatility
MRC Beta3.48
Industry Beta3
Market Beta1

Stable Share Price: MRC is more volatile than 75% of Polish stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: MRC's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Polish stocks.

About the Company

FoundedEmployeesCEOWebsite
19891,052Wieslaw Zyznowskihttps://mercatormedical.eu

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables in Europe, Russia, and internationally. The company offers surgical gloves for conducting invasive surgeries that require sterile conditions; sterile examination and protective gloves for medical, outpatient, and diagnostic examinations, as well as therapeutic activities and working with septic materials; household gloves for use in gardening, housework, and food procedures; and protective and heavy-duty gloves. It also provides dressing products, such as gauze, non-woven fabric, non-woven cotton, sterile adhesive, and plaster dressing products, as well as medical adhesive tapes, elastic tubular bandages, absorption pads, and dialysis kits; and medical protective clothing, including caps, masks, medical coats and gowns, shoe covers, oversleeves, coveralls, scrub suits, and patients shirts.

Valuation

Is Mercator Medical undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MRC (PLN166.1) is trading below our estimate of fair value (PLN10856.81)

Significantly Below Fair Value: MRC is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MRC is good value based on its PE Ratio (1.6x) compared to the European Medical Equipment industry average (39.7x).

PE vs Market: MRC is good value based on its PE Ratio (1.6x) compared to the Polish market (13.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MRC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MRC is good value based on its PB Ratio (1.3x) compared to the PL Medical Equipment industry average (3.5x).


Future Growth

How is Mercator Medical forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

15.2%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mercator Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Mercator Medical performed over the past 5 years?

89.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MRC has a high level of non-cash earnings.

Growing Profit Margin: MRC's current net profit margins (47.2%) are higher than last year (26.3%).


Past Earnings Growth Analysis

Earnings Trend: MRC's earnings have grown significantly by 89.4% per year over the past 5 years.

Accelerating Growth: MRC's earnings growth over the past year (379.8%) exceeds its 5-year average (89.4% per year).

Earnings vs Industry: MRC earnings growth over the past year (379.8%) exceeded the Medical Equipment industry 61.2%.


Return on Equity

High ROE: MRC's Return on Equity (79%) is considered outstanding.


Financial Health

How is Mercator Medical's financial position?


Financial Position Analysis

Short Term Liabilities: MRC's short term assets (PLN1.4B) exceed its short term liabilities (PLN285.2M).

Long Term Liabilities: MRC's short term assets (PLN1.4B) exceed its long term liabilities (PLN9.1M).


Debt to Equity History and Analysis

Debt Level: MRC is debt free.

Reducing Debt: MRC has no debt compared to 5 years ago when its debt to equity ratio was 65.3%.

Debt Coverage: MRC has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: MRC has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Mercator Medical current dividend yield, its reliability and sustainability?

0.30%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MRC's dividend (0.3%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.09%).

High Dividend: MRC's dividend (0.3%) is low compared to the top 25% of dividend payers in the Polish market (6.03%).


Stability and Growth of Payments

Stable Dividend: MRC is not paying a notable dividend for the Polish market, therefore no need to check if payments are stable.

Growing Dividend: MRC is not paying a notable dividend for the Polish market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: MRC is not paying a notable dividend for the Polish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MRC's dividend in 3 years as they are not forecast to pay a notable one for the Polish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.7yrs

Average management tenure


CEO

Wieslaw Zyznowski (57 yo)

11.67yrs

Tenure

zł1,944,100

Compensation

Dr. Wieslaw Zyznowski has been the Chairman of Management Board at Mercator Medical Spólka Akcyjna since 2010. In the 90s Dr. Zyznowski co-founded the Mercator. From 1991 to 2001 he served as (apart from a...


CEO Compensation Analysis

Compensation vs Market: Wieslaw's total compensation ($USD497.34K) is above average for companies of similar size in the Polish market ($USD320.03K).

Compensation vs Earnings: Wieslaw's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: MRC's management team is considered experienced (2.7 years average tenure).


Board Members

Experienced Board: MRC's board of directors are considered experienced (7.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Mercator Medical S.A.'s employee growth, exchange listings and data sources


Key Information

  • Name: Mercator Medical S.A.
  • Ticker: MRC
  • Exchange: WSE
  • Founded: 1989
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: zł1.768b
  • Shares outstanding: 10.65m
  • Website: https://mercatormedical.eu

Number of Employees


Location

  • Mercator Medical S.A.
  • Heleny Modrzejewskiej 30
  • Kraków
  • 31-327
  • Poland

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/17 22:30
End of Day Share Price2021/09/17 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.